Search hospitals > Wisconsin > Manitowoc
Holy Family Memorial Hospital
Claim this profileManitowoc, Wisconsin 54220
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
145 reported clinical trials
2 medical researchers
Summary
Holy Family Memorial Hospital is a medical facility located in Manitowoc, Wisconsin. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Lung Cancer, Ovarian Cancer and other specialties. Holy Family Memorial Hospital is involved with conducting 145 clinical trials across 335 conditions. There are 2 research doctors associated with this hospital, such as Matthew L. Ryan and Brian L. Burnette.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage III
2Recurrence
Global LeaderStage IV
Stage I
Stage III
Top PIs
Matthew L. RyanSaint Vincent Hospital Cancer Center Green Bay1 year of reported clinical research
Expert in Cancer
Studies Recurrence
45 reported clinical trials
103 drugs studied
Brian L. BurnetteSaint Vincent Hospital Cancer Center Green Bay4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
82 drugs studied
Clinical Trials running at Holy Family Memorial Hospital
Non-Small Cell Lung Cancer
Lung Cancer
Ovarian Tumors
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Germ Cell Tumors
Testicular Choriocarcinoma
Testicular Tumor
Embryonal Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Holy Family Memorial Hospital?
Holy Family Memorial Hospital is a medical facility located in Manitowoc, Wisconsin. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Lung Cancer, Ovarian Cancer and other specialties. Holy Family Memorial Hospital is involved with conducting 145 clinical trials across 335 conditions. There are 2 research doctors associated with this hospital, such as Matthew L. Ryan and Brian L. Burnette.